NEOMIDS Trademark

Trademark Overview


On Tuesday, April 26, 2022, a trademark application was filed for NEOMIDS with the United States Patent and Trademark Office. The USPTO has given the NEOMIDS trademark a serial number of 79351090. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by KANGPU BIOPHARMACEUTICALS, LTD.. The NEOMIDS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Demonstration of goods; advertising services; business management assistance; market research studies; commercial administration of the licensing of the goods and services of others; organization of exhibitions for commercial or advertising purposes; provision of an on-line marketplace for buyers and sellers of goods and services; import-export agency services; systemization of information into computer databases; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale drug store services; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical supplies

Technological research in the field of pharmaceutical, veterinary and sanitary preparations; scientific research; research and development of new products for others; cancer research for medical purposes in the area of cancerous diseases; quality control for others; chemistry services, namely, laboratory research and analysis in the field of chemistry; chemical research; medical research; medical and scientific research, namely, conducting clinical trials for others; bacteriological research; biological research; conducting early medical evaluations in the field of new pharmaceutical drugs and conducting early medical evaluations in the field of the implementation of new pharmaceutical drugs; laboratory research in the field of pharmaceutical drug evaluation and scientific research in the field of pharmaceutical drug evaluation and pharmaceutical drug product evaluation; pharmaceutical drug research; laboratory pharmaceutical drug testing and scientific research in the field of pharmac...
neomids

General Information


Serial Number79351090
Word MarkNEOMIDS
Filing DateTuesday, April 26, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7307304
Registration DateTuesday, February 20, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesDemonstration of goods; advertising services; business management assistance; market research studies; commercial administration of the licensing of the goods and services of others; organization of exhibitions for commercial or advertising purposes; provision of an on-line marketplace for buyers and sellers of goods and services; import-export agency services; systemization of information into computer databases; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale drug store services; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical supplies
Goods and ServicesTechnological research in the field of pharmaceutical, veterinary and sanitary preparations; scientific research; research and development of new products for others; cancer research for medical purposes in the area of cancerous diseases; quality control for others; chemistry services, namely, laboratory research and analysis in the field of chemistry; chemical research; medical research; medical and scientific research, namely, conducting clinical trials for others; bacteriological research; biological research; conducting early medical evaluations in the field of new pharmaceutical drugs and conducting early medical evaluations in the field of the implementation of new pharmaceutical drugs; laboratory research in the field of pharmaceutical drug evaluation and scientific research in the field of pharmaceutical drug evaluation and pharmaceutical drug product evaluation; pharmaceutical drug research; laboratory pharmaceutical drug testing and scientific research in the field of pharmaceutical drug testing; pharmaceutical drug development services; pharmaceutical drug research and development; medical and pharmaceutical drug research services; pharmaceutical research services; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; laboratory research in the field of pharmaceutical drug detection and scientific research in the field of pharmaceutical drug detection; material testing; software as a service (SaaS) featuring software for use in database management, collecting and analyzing medical and scientific data

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 1, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 1, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 3, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 19, 2023CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sunday, June 11, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, April 25, 2023REFUSAL PROCESSED BY IB
Tuesday, April 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 4, 2023REFUSAL PROCESSED BY MPU
Thursday, February 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 15, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB